RHA
LIVE

Serial Number

79434362

Owner

TEOXANE S.A.

Attorney

Jennifer C. Debrow

Filing Date

Jul 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RHA Trademark

Serial Number: 79434362

RHA is a trademark filed by TEOXANE S.A. on July 23, 2025. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

TEOXANE S.A. (13 trademarks)

105, rue de Lyon
Genève CH1203 , CH

Entity Type: 11

Trademark Details

Filing Date

July 23, 2025

Registration Date

Not Registered

Published for Opposition

May 12, 2026

Goods & Services

Cosmetic preparations in cream, milk, oil, emulsion, fluid and lotion form for the face, body, hair and hands; anti-wrinkle treatment creams; anti-aging creams for cosmetic use; cosmetic masks for facial care; cleansing preparations and make-up removers; micellar cleansing gels, foams and waters; anti-wrinkle cosmetic facial masks; non-medical preparations for skin, face and body care; day cream; night cream; sunscreen creams for cosmetic use; serum for cosmetic use; eye contour cream; lip contour cream; lip balms; perfumes; perfumery; cosmetic preparations for skin care and treatment; face and body make-up; cosmetic washing and bleaching preparation; hair washing, treating and grooming preparations; make-up; cosmetic dyes and mouthwashes, not for medical purposes; non-medicated soaps; non-medicated anti-aging skin care preparations

Surgical apparatus and instruments for medical use; medical syringes for injection of dermatological products; suture materials; injectors for medical use; lasers for cosmetic treatment of the skin and face; injection devices for pharmaceutical products; injection instruments without needles; multi-injection needle syringes; injection needles for medical use; genetic analysis apparatus for medical use; clinical diagnosis apparatus, namely, Ultrasound diagnostic apparatus, Medical diagnostic apparatus for detecting cancer, Medical diagnostic apparatus for testing DNA and RNA samples; diagnostic imaging apparatus for medical use

Dermo-cosmetic preparations and pharmaceutical products, namely, Pharmaceutical preparations for use in dermatology, Dermatologicals, medicated skin creams; skin creams and serums for medical use; sterile implantable products administered by injection for filling wrinkles, fine lines, skin depressions, namely, injectable dermal fillers; pharmaceutical or dermatological preparations injected into or under the skin, into or under the mucous membranes to fill wrinkles and skin depressions; pharmaceutical or dermatological preparations injected into or under the skin, into or under the mucous membranes for reshaping or increasing the volume of the face or any other part of the body; pharmaceutical or dermatological preparations injected into or under the skin, into or under the mucous membranes to increase lip volume; pharmaceutical or dermatological preparations injected into or under the skin, into or under the mucous membranes for hydrating the skin or mucous membranes; wound healing products for medical or sanitary use, namely, Pharmaceutical preparations for wounds, Medical adhesive strips for closing wounds or incisions, Wound dressings; anesthetics for surgical use; injectable dermal fillers; pharmaceutical agent for the epidermis; creams for dermatological use; medicated lotions and creams for the body, skin, face and hands; disinfectants

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2026 TROA
REFUSAL PROCESSED BY IB
Feb 12, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 23, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 23, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 21, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 20, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 9, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 10, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 9, 2025 REPR